Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
SM Deyev, EN Lebedenko - Bioessays, 2008 - Wiley Online Library
High‐precision tumor targeting with conventional therapeutics is based on the concept of the
ideal drug as a “magic bullet”; this became possible after techniques were developed for …
ideal drug as a “magic bullet”; this became possible after techniques were developed for …
Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.
SM Deyev, EN Lebedenko - … and Reviews in Molecular, Cellular and …, 2008 - europepmc.org
High-precision tumor targeting with conventional therapeutics is based on the concept of the
ideal drug as a" magic bullet"; this became possible after techniques were developed for …
ideal drug as a" magic bullet"; this became possible after techniques were developed for …
Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
SM Deyev, EN Lebedenko - BioEssays: news and …, 2008 - pubmed.ncbi.nlm.nih.gov
High-precision tumor targeting with conventional therapeutics is based on the concept of the
ideal drug as a" magic bullet"; this became possible after techniques were developed for …
ideal drug as a" magic bullet"; this became possible after techniques were developed for …
[引用][C] Multivalency: The hallmark of antibodies used for optimization of tumor targeting by design
SM Deyev, EN Lebedenko - BioEssays, 2008 - elibrary.ru
Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
SM Deyev, EN Lebedenko - 2008 - philpapers.org
High‐precision tumor targeting with conventional therapeutics is based on the concept of the
ideal drug as a “magic bullet”; this became possible after techniques were developed for …
ideal drug as a “magic bullet”; this became possible after techniques were developed for …